Publications
Raymond
S. Fersko
New:
The Devil Is In the Details
BioExecutive International, September 2005He Should Have Armed Himself
BioExecutive International, May 2005Science, Profit and Public Dissemination of Information: A Discussion of Human Embryonic Stem Cell Research
Co-Written with Hind Merabet
Drug Development Research, 2005Hatch Waxman: A Work in Progress
Responding to the Conundrum: How to Encourage Innovative New Drugs While Reducing the Cost of Access
Co-Written with Eugene Trogan and Pamela Harinstein
Journal of Biolaw and Business, forthcoming in 2005Cross-Border Transaction: A Roadmap for Commercial Arrangements between North-American and European Companies
Co-Written with Hind Merabet and Valentina Cordioli
Journal of Commercial Biotechnology, 2004Biologics Move Off Patent But New Paradigms Are Unlikely To Emerge In the Absence Of Public Or Private Economic Incentives
Co-Written with Nazlie S. Latefi
Journal of Biolaw and Business, 2004An American in Vienna
Presented at the Vienna Business Meeting in Boston on September 30, 2004Better Nouveau Than Never
Financier Worldwide: Biotechnology Sector Review 2004
Articles:
Enabling the Future – Biotechnology Law as a Separate Discipline
BioExecutive International, June 2006
Taking Aim at the AIM
BioExecutive International, May 2006
The Devil Is In the Details
BioExecutive International, September 2005
He Should Have Armed Himself
BioExecutive International, May 2005
Science, Profit and Public Dissemination of Information: A Discussion of Human Embryonic Stem Cell Research
Co-Written with Hind Merabet
Drug Development Research, 2005
Cross-Border Transaction: A Roadmap for Commercial Arrangements between North-American and European Companies
Co-Written with Hind Merabet and Valentina Cordioli
Journal of Commercial Biotechnology, 2004
Biologics Move Off Patent But New Paradigms Are Unlikely To Emerge In the Absence Of Public Or Private Economic Incentives
Co-Written with Nazlie S. Latefi
Journal of Biolaw and Business, 2004
An American in Vienna
Presented at the Vienna Business Meeting in Boston on September 30, 2004
Better Nouveau Than Never
Financier Worldwide: Biotechnology Sector Review 2004
Aids Efforts Spark Patent Concerns
New Jersey Law Journal
Intellectual Property Law Supplement, July 12, 1993
The Art of Cross-Pond Negotiations: Finding a Foreign Partner
Journal of Commercial Biotechnology, Vol.5, No. 3, 1999
Bio Seeks Partner
Unlimited (New Zealand), October 2002Bionegotiation: Points to Consider in Negotiating Global Research & Development
The Journal of BioLaw & Business, Vol 4, No 4, 2002Aids Efforts Spark Patent Concerns
New Jersey Law Journal
Intellectual Property Law Supplement
July 12, 1993
Format: TextThe Art of Cross-Pond Negotiations: Finding a Foreign Partner
Journal of Commercial Biotechnology
Vol.5, No. 3, 1999
Format: TextBio Seeks Partner
Unlimited (New Zealand)
October 2002
Format: TextBionegotiation: Points to Consider in Negotiating Global Research & Development
The Journal of BioLaw & Business
Vol 4, No 4, 2002
Format: TextCollaborative Agreements in Biotechnology:
Issues in Global Negotiations from the U.S. Perspective
The Journal of BioLaw & Business
Vol 5, No 2, 2002
Format: PDFCon Tacto y Cautela se Evitan Conflictos en Negociaciones Internacionales
Oil & Gas Journal Revista Latinoamericana
January 1996
Format: PDFExperts’ Picks, Bio 2002
Guest Editorial: Doing Business Globally
Biotech Magazine
Bio 2002 Edition
Format: TextExperts’ Picks, Bio 2002
Guest Editorial: The Finance Track
Biotech Magazine
Bio 2002 Edition
Format: TextExperts’ Picks, Bio 2003
Guest Editorial: Doing Business Globally Track
Biotech Magazine
Bio 2003 Edition
Format: TextForming Biotech Collaborative Deals: Avoiding the Headaches
Trade New Zealand
Format: PDFGenomic and Enabling/Platform Technology Companies in Transition
Journal of Drug Development Research
Annual Edition 2002
Format: TextIntellectual Property Issues in a Clinical Trial: A Corporate Perspective
Quality Assurance: Good Practice, Regulation, and Law
June 1992
Format: PDFIntroduction/Special Supplement
The Journal of Biolaw & Business
Bio-Education Special Supplement, 2003
Format: PDFLegal Issues Pertaining to Cloning
Quality Assurance, Good Practice, Regulation and Law
March 1998
Format: PDFProtect Your Ideas
The Scientist
December 9, 2002
Format: TextRethinking the “Most-Favored-Licensee” Clause
After Studiengesellschaft Kohl, M.B.H. v. Hercules, Inc.
Intellectual Property Law Newsletter
Spring 1998
Format: TextScylla and Charybdis
The Daily Deal
May 15, 2001
Format: TextTechnology Transfer and the Biotechnology Industry
Executive Summary of Report to the President and Congress
BIO 1995
Format: TextWebcasting and U.S. Law
Video Age International
October 1998
Format: TextPresentations:
Biotech to Biotech
October 12, 2000
Presented at New York Biotechnology Association Annual Meeting
Format: PPTCareers in Law and Technology Licensing
September 11, 2001, January 17, 2002
Visions for the Future – Annual Bioscience Career Conference
Center for Biotechnology at SUNY Stony Brook
Format: PPTCommercializing Biotechnology
“Drugs and Disease”
Columbia University
November 19, 2001
Format: PPTCreation of Value through Technology:
Perspectives from Buyers, Sellers and the Street
BIO 2002
June 12, 2002
Format: PPTEffects of Globalization Upon the Accessing of Intellectual Property
Drug Information Association 10th Annual Workshop
Biotechnology – Electronic IND Submissions and Global Issues
March 25-28, 2002
Irvine, California
Format: PPTThe Future of Collaborative Research Agreements
May 23, 1995
Tech Transfer Breakout Session
Format: TextGlobal Biotechnology Transactions
September 11, 2001
Created for US/Taiwan Biotechnology Initiative
Sponsored by US Trade and Development Agency
Format: PPTInternational Technology Transfer
Foundation for the Advanced Education in the Sciences
Spring 2003 Technology Transfer Course
May 15, 2003
Format: PPTLife Science Licensing
Center for International Legal Studies
October 5, 2003
Salzburg, Austria
Format: PPTMaximizing the Value of Technology Trends in Biotechnology
November 21-22, 2002
Vienna, Austria
Format: PPTNegotiating and Documenting Domestic/International Alliances
November 16, 2001
U.S./Taiwan Partnering in Global Bio/Pharma – 2001 and Beyond
Format: PPTThe Overview
Biotechnology Business & Law
Fall 2002, August 27, 2002
Format: PPTOverview of Commercializing Biotechnology Genetics, Biotechnology & Public Health:
Contemporary Issues and Challenges
Harvard School of Public Health
May 13, 2003
Format: PPTPartnering and Access to Genomic and “Enabling/Platform” Technologies
August 14-15, 2001
Format: PPTPrenuptials for the R&D Agreement
June 27, 2001
Presented at BIO 2001
Format: PPTPresentation for the U.S. Mexico Chamber of Commerce
June 2001
Format: TextReport Back from the Chimpanzee Wars: Selected Legal Issues
National Association for Biomedical Research Conference 2003
Washington, DC
February 23-25, 2003
Format: PPTTo Disclose or What To Disclose?
NYBA 11th Annual Meeting
FDA and the Investor Panel
March 18, 2002
Format: PPTUS Issues in Collaborative Agreements
Allen & Overy/Mintz Levin Bioscience Forums
March 20, 2001, November 27-28, 2001
Format: PPT
© Ferskos LLC. Terms of Use